Literature DB >> 26665124

The role of preoperative ultrasonography, computed tomography, and sestamibi scintigraphy localization in secondary hyperparathyroidism.

Jae Bok Lee1, Woo Young Kim1, Yu-Mi Lee2.   

Abstract

PURPOSE: The role of preoperative localization studies is controversial in surgery of secondary hyperparathyroidism (sHPT). The aim of study was to evaluate the accuracy of preoperative ultrasonography (USG), CT, and (99m)Tc sestamibi scintigraphy (MIBI) in localizing enlarged parathyroid glands and to find the impact of correct localization in successful parathyroidectomy.
METHODS: We compared operative findings with the preoperative localization of ultrasonography, computerized tomography and sestamibi scintigraphy in 109 patients with sHPT and identified well-visualized locations of abnormal parathyroid glands by evaluating the sensitivity of each imaging study with regard to typical locations of glands. We investigated the effect of preoperative imaging localization on the surgical outcomes by measuring the intraoperative parathyroid hormone (ioPTH) decrement for positive or negative imaging localization.
RESULTS: USG (91.5%) had the highest sensitivity and MIBI (56.1%) had the lowest among 3 modalities. The sensitivity of combined USG and CT (95.0%) was the highest among combined 2 modalities. The combination of all 3 modalities (95.4%) had the highest sensitivity among the combinations of modalities. The reduction of ioPTH in patients with positive imaging localization (86.6%) was greater than negative imaging localization (84.2%), with no significant difference (P = 0.586). The recurrence or persistence of sHPT was not correlated with preoperative imaging localization (19 patients in negative, 16 in positive; P = 0.14).
CONCLUSION: Preoperative imaging localization contributed to surgical success but not to surgical outcomes. The combination of ioPTH measurement with imaging localization might be valuable for better surgical results in sHPT.

Entities:  

Keywords:  Hyperparathyroidism; Technetium Tc 99m Sestamibi; Ultrasonography; X-ray computed tomography

Year:  2015        PMID: 26665124      PMCID: PMC4672093          DOI: 10.4174/astr.2015.89.6.300

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


  28 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal.

Authors:  Miguel Echenique Elizondo; Francisco Javier Díaz-Aguirregoitia; José Antonio Amondarain; Fernando Vidaur
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

Review 3.  Intraoperative parathyroid hormone monitoring.

Authors:  William B Inabnet
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

Review 4.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

5.  The accuracy of 99m Tc-MIBI scintigraphy for preoperative parathyroid localization in primary and secondary-tertiary hyperparathyroidism.

Authors:  Yuthana Saengsuda
Journal:  J Med Assoc Thai       Date:  2012-03

6.  Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism.

Authors:  Sophie Périé; Hafedh Fessi; Marc Tassart; Nassima Younsi; Isabelle Poli; Jean Lacau St Guily; Jean-Noël Talbot
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

7.  Secondary and tertiary hyperparathyroidism: role of preoperative localization.

Authors:  Eric C H Lai; Alex S C Ching; Heng Tat Leong
Journal:  ANZ J Surg       Date:  2007-10       Impact factor: 1.872

8.  Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism.

Authors:  Carlo Vulpio; Maurizio Bossola; Annamaria De Gaetano; Giulia Maresca; Isabella Bruno; Guido Fadda; Francesca Morassi; Sabina C Magalini; Alessandro Giordano; Marco Castagneto
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

9.  Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism.

Authors:  Andrea Trombetti; Catherine Stoermann; John H Robert; François R Herrmann; Pietra Pennisi; Pierre-Yves Martin; René Rizzoli
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

10.  Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs).

Authors:  Avital Harari; Elliot Mitmaker; Raymon H Grogan; James Lee; Wen Shen; Jessica Gosnell; Orlo Clark; Quan-Yang Duh
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

View more
  9 in total

1.  The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism.

Authors:  Mechteld C de Jong; K Jamal; S Morley; T Beale; T Chung; S Jawad; S Hurel; H Simpson; U Srirangalingam; S E Baldeweg; V Rozalén García; S Otero; M Shawky; T E Abdel-Aziz; T R Kurzawinski
Journal:  Hormones (Athens)       Date:  2020-05-13       Impact factor: 2.885

2.  Lesion based diagnostic performance of dual phase 99mTc-MIBI SPECT/CT imaging and ultrasonography in patients with secondary hyperparathyroidism.

Authors:  Panli Li; Qiufang Liu; Daoqiang Tang; Yinyan Zhu; Lian Xu; Xiaoguang Sun; Shaoli Song
Journal:  BMC Med Imaging       Date:  2017-12-12       Impact factor: 1.930

3.  Intraoperative Parathyroid Localization with Near-Infrared Fluorescence Imaging Using Indocyanine Green during Total Parathyroidectomy for Secondary Hyperparathyroidism.

Authors:  Le Cui; Yang Gao; Heping Yu; Min Li; Birong Wang; Tao Zhou; Qinggang Hu
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Parathyroidectomy in the treatment of BMD-DRC Brazil: many limitations, but still fundamental.

Authors:  Lilian P F Carmo
Journal:  J Bras Nefrol       Date:  2018-11-14

5.  Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study.

Authors:  Takahisa Hiramitsu; Toshihide Tomosugi; Manabu Okada; Kenta Futamura; Makoto Tsujita; Norihiko Goto; Shunji Narumi; Yoshihiko Watarai; Yoshihiro Tominaga; Toshihiro Ichimori
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

6.  Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism.

Authors:  Haoyang Ma; Chun Ouyang; Yaoyu Huang; Changying Xing; Chen Cheng; Wei Liu; Donglan Yuan; Ming Zeng; Xiangbao Yu; Haibin Ren; Yanggang Yuan; Lina Zhang; Fangyan Xu; Ying Cui; Wenkai Ren; Hui Huang; Hanyang Qian; Boqiang Fan; Ningning Wang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

7.  Diagnostic Accuracy of Intraoperative Intact Parathyroid Hormone Monitoring for Surgical Outcomes of Secondary Hyperparathyroidism.

Authors:  Yuanyuan Chen; Bin Liang; Xiaofeng Dong; Tao Huang; Tian-Qi Liu
Journal:  Med Sci Monit       Date:  2021-11-28

8.  Craniofacial Brown Tumor in Patients with Secondary Hyperparathyroidism to Chronic Renal Failure: Report of Two Cases in Cipto Mangunkusumo Hospital.

Authors:  Diani Kartini; Maria K Siswiandari; Gunawan Wibisana; Erwin D Yulian; Ahmad Kurnia; Sonar S Panigoro; Azdi Z Albar; Muchlis Ramli
Journal:  Case Rep Oncol Med       Date:  2018-09-12

Review 9.  Preoperative and Intraoperative Methods of Parathyroid Gland Localization and the Diagnosis of Parathyroid Adenomas.

Authors:  Jacek Baj; Robert Sitarz; Marek Łokaj; Alicja Forma; Marcin Czeczelewski; Amr Maani; Gabriella Garruti
Journal:  Molecules       Date:  2020-04-09       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.